mutations in one of either MSH2, MLH1, PMS1 or PMS2 (9) and are characterized by a high incidence of colon cancer at Department of Medical Genetics, University of Alberta, Edmonton, an early age, as well as an increased predisposition to tumors AB T6G 2H7 Canada, 1 Departments of Therapeutic Radiology and of the endometrium, gastrointestinal tract and skin (10,11).
known biochemical role and Pms1 knockout mice are not DNA mismatch repair (MMR) deficiency leads to an prone to tumorigenesis (13) , so the role of PMS1 in mutation increased mutation frequency and a predisposition to neoavoidance may be restricted to specific sequences and may be plasia. 'Knockout' mice deficient in the MMR proteins tissue and/or cell type specific. In the absence of MMR, tumor Msh2 and Pms2 crossed with mutation detection reporter development or progression is thought to be accelerated due (supF, lacI and cII) transgenic mice have been used to to the resulting hypermutability, with mutations accumulating facilitate a comparison of the changes in mutation frequency in key tumor suppressor genes, oncogenes and other genes and spectra. We find that the mutation frequency was involved in growth control (12) . consistently higher in Msh2-deficient mice than Pms2-Mice lacking Pms2 and Msh2 have provided a model system deficient mice. The lacI target gene, which is highly sensitive to study the roles of the specific MMR proteins in DNA repair to point mutations, demonstrated that both Msh2-and and cancer (13) (14) (15) (16) . Mice deficient in any one of the MMR Pms2-deficient mice accumulate transition mutations as proteins, except Pms1, are characterized by increased tumor the predominant mutation. However, when compared with development after 2 months of age (13) . The presence and Msh2 -/-mice, lacI and cII mutants from Pms2-deficient early onset of tumors is further supporting evidence of the mice revealed an increased proportion of ⍣/-1 bp vital role Pms2 and Msh2 are assumed to play in maintaining frameshift mutations and a corresponding decrease in a stable genome and suggests that both molecules play an transversion mutations. The supF target gene, which is important role in murine tumorigenesis. However, mice sensitive to frameshift mutations, and the cII target gene lacking various components of the MMR complex all demonrevealed a strong tendency for -1 bp deletions over ⍣1 bp strate differences with respect to tumor spectrum (13, 17, 18 ) insertions in Msh2 -/-compared with Pms2 -/-mice. These consistent with differing functional roles of specific MMR data indicate that Msh2 and Pms2 deficiency have subtle molecules or possibly reflecting subtle differences in residual but differing effects on mutation avoidance which may repair or partial redundancy from MMR gene paralogs. Msh2 -/-contribute to the differences in tumor spectra observed in mice develop sarcomas, lymphomas, skin neoplasms and the two 'knockout' mouse models. These variances in intestinal tumours (13, (16) (17) (18) , whereas Pms2 -/-mice develop mutation accumulation may also play a role, in part, in only lymphomas and sarcomas (13, 14) . The various MMR the differences seen in prevalence of MSH2 and PMS2 knockouts have been constructed in two different strains of germline mutations in hereditary non-polyposis colorectal 129 (Ola and Sv) which may account for some of the cancer patients.
differences in tumor spectra, however, the effect of substrain variability on MMR is likely subtle compared with the MMR Introduction deficiency itself (13) (14) (15) (16) (19) (20) (21) . Mutation detection transgenic mice are invaluable for The current mammalian model of DNA mismatch repair investigating the role of MMR deficiency at the single gene (MMR) implicates MSH2 (1,2) as being critical for the initial level in vivo. The incorporation of a retrievable reporter gene recognition of mismatches. Heterodimers formed between such as lacI, supF or cII into a murine host makes possible MSH2 and either MSH3 or MSH6/GTBP (3,4) are necessary the collection of tissue-specific mutation frequency data and for repair of single base mismatches or small insertions or mutant recovery. Sequencing of the recovered mutant genes deletions (5). Recruitment of a second heterodimer, made up provides the opportunity to determine gene-specific mutation of PMS2 (6) and MLH1 (7, 8) , is thought to be necessary for spectra on different MMR-deficient backgrounds as mutations subsequent excision and resynthesis necessary to repair the within the reporter genes may reflect those occurring within region containing the mismatched base(s) (2).
endogenous genes. Previous data from Msh2 -/-/lacI and Pms2 -/-/supF mice demonstrated dramatically different levels of mutation
The cII gene of phage λ can also be used as a reporter gene in λ-based frequency and differences in mutation spectra (22, 23 Msh2 -/-/lacI mice. As Msh2 and Pms2 are thought to interact For all reporter gene assays, mutation frequency was obtained by counting a minimum of 100 000 p.f.u./tissue/animal to provide a reliable ratio of in a multiprotein complex and both are thought to be essential mutants to non-mutants.
for functional MMR repair, the quantitative and qualitative Statistical comparisons differences in the two 'knockout' mice required further Raw numbers of mutants observed, over total number of plaques screened, investigation. It was possible that the mutation differences were used for statistical comparisons of mutation frequencies. Pairwise reflected the different nature of the two target genes used in comparisons between mutation frequencies from Msh2 -/-and Pms2 -/-were the different studies. Alternatively, the consequences of losing performed using a χ 2 test of homogeneity (df ϭ 1) for each reporter gene Msh2 or Pms2 may not have been equivalent in terms of used and data for Msh2 -/-from all three reporter genes were compared with Pms2 -/-data, also using a χ 2 test of homogeneity (df ϭ 2).
resulting mutability, with loss of Pms2, for example, leading Sequence spectra were also analyzed using a χ 2 test of homogeneity.
to greater instability.
In order to determine the potential differences of Msh2 and Results Pms2 deficiency on DNA mutation, Pms2 -/-and Msh2 -/-mice were bred to both supF-and lacI-containing mice, thus allowing
Higher spontaneous mutation frequencies in Msh2 -/-versus mutation frequencies and spectra to be directly compared. The
Pms2 -/-mice cII gene of phage carrying the supF reporter was also used as Mutation frequencies were determined for DNA from several a third target gene to compare mutation frequencies between mouse tissues using lacI, supF and cII as target genes and Pms2 and Msh2 null mice. The results from all reporter genes compared with wild-type mice ( Figure 1 ; 22, 23) . The supF suggest that mutation frequencies may be higher in animals and cII data are not independent, as the assays are done with lacking Msh2 than in those deficient in Pms2. Pms2 -/-mice linked phage λ reporters. With the lacI and supF reporter had a greater proportion of frameshift mutations and fewer assays, mutation frequencies for Msh2 ϩ/-or Pms2 ϩ/-heterotransversions than Msh2 -/-mice. Furthermore, while both zygous mice were not significantly different from those of ϩ1 and -1 bp frameshifts were recovered from Pms2 -/-wild-type mice. However, mutation frequencies in lacI from mice, frameshift mutations obtained from Msh2 -/-mice were Msh2 and Pms2 nullizygous mice were 15-and 10-fold higher, predominantly deletions. These differences between Msh2-respectively, than those of wild-type mice. When the supF and Pms2-deficient mice suggest that these two proteins have gene was used, Msh2 -/-mice had a 163-fold increase in different roles in DNA damage or mispair identification and mutation frequency over controls and Pms2 -/-mice had, on repair. These differences may account for variations in cancer average, a 100-fold increase (23) . Using the cII gene to predisposition between the 'knockout' mice and suggest a determine mutation frequencies, Msh2 and Pms2 null mice plausible explanation for the lower incidence of Pms2 germline were 45-and 5-fold higher than wild-type mice, respectively. mutations in HNPCC patients (24) .
Interestingly, Msh2-deficient mice had consistently higher mutation frequencies than Pms2-deficient mice with all assay Materials and methods systems when analyzed by χ 2 test of homogeneity (all P Ͻ Transgenic mice and genotype testing 0.0000, df ϭ 1) (Figure 1 ).
Pms2-deficient mice created through gene targeting in embryonic stem cells
Pms2 -/-mutation spectrum differs from that of Msh2 -/-mice (14) were crossed with transgenic lines carrying either a lacI (25) or a supF mutational reporter gene (26, 27) to obtain Pms2 ϩ/ϩ /lacI, Pms2 ϩ/-/lacI and LacI, supF and cII mutants were isolated, purified and the Pms2 gene and carrying the lacI gene, all 3-4 weeks old, were chosen for analysis. Previous data generated from Msh2 ϩ/ϩ /lacI and Msh2 -/-/lacI
When lacI mutants collected from Pms2 -/-thymus and small mice were used for comparison (22) . Three Msh2 ϩ/-/supF mice and six intestine were sequenced, transitions were the predominant Msh2 ϩ/ϩ /supF mice, all 6 weeks of age, were also analyzed and compared with mutation (58% of all mutations), followed by -1 bp deletions data previously generated from Pms2 ϩ/ϩ /supF and Pms2 -/-/supF mice (23).
(28%), transversions (8%) and ϩ1 bp insertions (6%) ( DNA was isolated from tissues from lacI transgenic mice as previously described (25). The lacI phage transgenes were excised from chromosomal ϩ1 bp insertions, which was significantly different from the DNA and packaged into phage particles with Transpack phage packaging breakdown of mutations from the Pms2 -/-mice when compared extract (Stratagene). Phage containing rescued lacI transgenes were plated on by χ 2 analysis (P Ͻ 0.001, df ϭ 3).
SCS-8 bacterial lawns (Stratagene) in the presence of X-gal. Mutants appeared
When supF mutants from Msh2 -/-and Pms2 -/-mice were as blue plaques among the non-mutant, colorless plaques. Mutants were analyzed, the spectra were very different from those obtained verified by replating and sequenced using various primers spanning the lacI gene (25).
using the lacI reporter (Table I) . This is consistent with
For the supF reporter gene assay, DNA was isolated and packaged and previous findings that the supF gene is highly sensitive to ϩ/-plated as before (23) . Functional supF genes suppress the nonsense mutation 1 bp insertion and deletion mutations occurring within coding in the host bacteria β-galactosidase gene, yielding blue plaques, whereas runs of C 7 and G 8 mononucleotide repeats. However, in mutations inactivating the supF gene produce colorless phage plaques. Mutants were sequenced as previously described (23).
comparing Msh2-and Pms2-deficient animals, deletions were five times more prevalent than insertions in Msh2 nulls, Discussion whereas mutants recovered from Pms2-deficient mice included
The model of MMR suggests that both Msh2 and Pms2 are relatively fewer deletions and more insertions, at a ratio of essential for MMR and the absence of either one would have 2:1 (Table I ; χ 2 analysis, P Ͼ 0.0001, df ϭ 1). similar consequences with respect to mutation accumulation. The cII gene provided a third reporter gene sequence for Our previous studies with different reporter genes suggested, mutational comparisons. Msh2 -/-mice demonstrated transhowever, that greater mutability might result from Pms2 versions and transitions as the predominant mutation type, deficiency (22, 23) . The Pms2 -/-/supF mice, containing the with -1 bp deletions again outweighing ϩ1 bp insertions supF target gene with two mononucleotide runs of C 7 and G 8 , (Table I) . Pms2 -/-mice demonstrated mostly frameshift demonstrated a mutation frequency that was 100-fold higher mutations, with no transversions; a similar mutation spectrum than that of controls (23) . In contrast, Msh2 -/-mice had a to that seen with the lacI and supF target genes. The breakmutation frequency only 13-fold higher than background as downs of mutation types in Msh2 -/-and Pms2 -/-mutants were determined by the lacI transgene, a target, however, that does significantly different by χ 2 test of homogeneity (P Ͻ 0.01, not contain a mononucleotide run greater than five bases (A 5 df ϭ 3). Pms2 -/-mice had proportionately twice as many ϩ1 at position 135). In order to directly compare the effects of bp insertions as Msh2 -/-mice, the ratio being consistent with that determined using the other two reporter genes.
Pms2 or Msh2 hemizygosity and nullizygosity on spontaneous mutation, in this study Pms2 -/-and Msh2 -/-mice were crossed most likely due to slippage of the nascent strand and deletion mutations result primarily from slippages on the template with three reporter genes for direct comparison of mutation frequency and spectra.
strand (30) , the MMR complex may be associated with the replication machinery in such a way that particular subsets of In this more comprehensive analysis, Msh2 -/-mice consistently demonstrated higher mutation frequencies than the MMR proteins recognize or act on particular pre-mutational events. For example, Pms2 might be positioned within a postPms2 -/-animals (P Ͻ 0.001, by χ 2 test of homogeneity) (Figure 1 ). Although there is some variability in that the replication complex such that it is primarily involved in the recognition or repair of nascent strand slippages, whereas differences in mutation frequencies ranged from 1.5-fold higher with the lacI gene to 7-fold higher with the cII gene, the Msh2 and Mlh1 may have roles in the monitoring and correction of both template and nascent strand slippage errors. results suggest that there is a measurable difference in vivo in the degree of genetic instability caused by Msh2 versus Pms2
This model would be consistent with the finding of relatively more deletion mutations in the absence of Msh2 and Mlh1 as deficiency.
The comparison between Pms2 -/-/lacI and Pms2 -/-/supF opposed to Pms2. Our data suggesting that MMR proteins have differing roles mice demonstrates the importance of the target gene when determining mutation frequencies or rates, as mutation frequenin error correction is in keeping with mutation spectra derived from comparisons performed in cell lines lacking either MSH2 cies were~6-fold lower with lacI than with the supF transgene in Pms2 -/-mice (23) . The increased number of mutations or MLH1, suggesting that each gene defect causes a specific mutator phenotype (31) . Also, analysis of immunoglobin gene in mononucleotide repeats in Pms2 -/-/supF compared with Pms2 -/-/lacI confirms that genes containing such repeats are variable region hypermutation in Msh2-and Pms2-deficient mice revealed different patterns of mutation depending on at high risk for mutation in MMR deficiency. This study therefore also highlights the importance of the particular which gene was absent, suggesting non-equivalent roles for these two proteins in this process (32). reporter gene used when assessing mutation patterns. For example, the lacI gene is most useful for the detection of
The differences in mutation frequency and spectra obtained from the reporter genes used in this study suggest that cells base substitutions, whereas the supF gene is particularly well suited to detection of frameshift mutations occurring at from patients having germline mutations in MSH2 or PMS2 may be prone to both quantitative and qualitiative differences mononucleotide repeats. The cII gene detects both point mutations as well as frameshifts, as it contains two coding N 6 in genomic instability once the wild-type allele is inactivated. Thus, the growth control genes at risk for mutation may differ mononucleotide runs.
Pms2 -/-/lacI mutants demonstrated a higher proportion of depending on the particular MMR gene lost. Pms2 -/-and Msh2 -/-mice differ considerably with respect to the incidence frameshift mutations (34 versus 23%) and a lower proportion of transversions (8 versus 13%) than that observed in Msh2-of small intestinal neoplasia (13, 17) . However, the prevalence of PMS2 ϩ/-mutations in HNPCC kindreds is too low to allow deficient mice using the same reporter, suggesting that these two mismatch repair deficiencies may not be equivalent in conclusions about PMS2 -/--deficient tumor predisposition in affected individuals. The lower incidence of Pms2 germline terms of error correction. An increase in the proportion of slippage mutations in Pms2 -/-/lacI animals at mononucleotide mutations detected in HNPCC patients (24) may be explained in part, however, by the differences in MMR protein function and dinucleotide repeats, consistent with mutations resulting from polymerase errors, suggests that Pms2 has a major role reported here. The effect of Msh2 deficiency on genome instability is more severe than that of Pms2, hence, critical in the pathway correcting slippage errors and that it has a lesser role in correcting base substitution mismatches, in which downstream target genes for carcinogenesis may differ in their risk of mutation depending on which MMR function is lost. case other MutL homologs may be sufficient.
A recent manuscript by Yao et al. (29) also supports the findings that the MMR proteins are not equivalent with respect
